Radiation therapy for older women with breast cancer
Part of Cancer clinical trials.
This trial tests a precise, high-dose radiation treatment (called SABR) for older women with early-stage breast cancer who choose not to have surgery. It aims to control the tumor with fewer side effects and may be an option if you have a small, ER+, HER2- tumor that hasn't spread to lymph nodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 65 or older with invasive breast cancer that is not being treated with surgery.
- Your breast tumor is 5 cm (2 inches) or smaller and has not spread to lymph nodes (node-negative).
- Your cancer is estrogen-receptor-positive (ER+) and HER2-negative.
- You have not had prior radiation to the same breast or chest area.
- You are not currently receiving chemotherapy for breast cancer (but prior hormone therapy or chemo is okay).
- Cancer must not have spread to other parts of the body (no distant metastases).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a precise type of radiation (SABR) given to the breast tumor in people with stage IV breast cancer. The goal is to see if targeting the breast tumor improves control of the disease and quality of life.
This study tests whether giving focused radiation (SABR) to a few growing spots of breast cancer, while continuing your current hormone therapy and CDK 4/6 inhibitor, can help control the cancer longer than switching to a different treatment. It is for people whose cancer is mostly stable but has a small number of spots that have started to grow.
This trial tests a precise type of radiation called SBRT for breast cancer in patients aged 70 or older who cannot have surgery or choose not to. The goal is to see if this treatment can effectively control the tumor without surgery.
This trial compares a newer, more targeted type of radiation (hotspot SABR) with the standard SABR approach for people with early-stage non-small cell lung cancer. The goal is to see if the newer method works just as well or better while possibly reducing side effects.
This trial tests a precise, high-dose radiation technique (SABR) for people whose cancer has started to grow again in only a few spots despite ongoing medication. The goal is to control those new growths while continuing your current treatment.
This trial tests whether adding focused, high-dose radiation (SABR) to standard drug therapy can better control cancer that has spread to a few spots in the body. It is for people starting or resuming cancer medicines for newly found or growing metastases.
Hear when a new Breast Cancer Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.